Neoadjuvant osimertinib with/without chemotherapy vs chemotherapy for EGFR mutated resectable NSCLC: NeoADAURA Meeting Abstract
| Authors: | Tsuboi, M.; Weder, W.; Escriu, C.; Blakely, C.; He, J.; Dacic, S.; Yatabe, Y.; Zeng, L.; Walding, A.; Chaft, J. |
| Abstract Title: | Neoadjuvant osimertinib with/without chemotherapy vs chemotherapy for EGFR mutated resectable NSCLC: NeoADAURA |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | neoadjuvant; osimertinib; stage ii-iiib nsclc |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S258 |
| Language: | English |
| ACCESSION: | WOS:000631349600362 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.375 |
| Notes: | Meeting Abstract: P03.02 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
